Show simple item record

dc.contributor.authorDorans, Kimberly
dc.contributor.authorChung, Katherine Minjee
dc.contributor.authorRobbins, Rebecca
dc.contributor.authorTammela, Tuomas
dc.contributor.authorGocheva, Vasilena
dc.contributor.authorJacks, Tyler E.
dc.contributor.authorLi, Carman Man Chung
dc.contributor.authorMuzumdar, Mandar
dc.date.accessioned2017-05-26T17:24:43Z
dc.date.available2017-05-26T17:24:43Z
dc.date.issued2016-07
dc.date.submitted2016-03
dc.identifier.issn2041-1723
dc.identifier.urihttp://hdl.handle.net/1721.1/109379
dc.description.abstractAlthough it has become increasingly clear that cancers display extensive cellular heterogeneity, the spatial growth dynamics of genetically distinct clones within developing solid tumours remain poorly understood. Here we leverage mosaic analysis with double markers (MADM) to trace subclonal populations retaining or lacking p53 within oncogenic Kras-initiated lung and pancreatic tumours. In both models, p53 constrains progression to advanced adenocarcinomas. Comparison of lineage-related p53 knockout and wild-type clones reveals a minor role of p53 in suppressing cell expansion in lung adenomas. In contrast, p53 loss promotes both the initiation and expansion of low-grade pancreatic intraepithelial neoplasia (PanINs), likely through differential expression of the p53 regulator p19ARF. Strikingly, lineage-related cells are often dispersed in lung adenomas and PanINs, contrasting with more contiguous growth of advanced subclones. Together, these results support cancer type-specific suppressive roles of p53 in early tumour progression and offer insights into clonal growth patterns during tumour development.en_US
dc.description.sponsorshipLustgarten Foundationen_US
dc.description.sponsorshipHoward Hughes Medical Instituteen_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (Cancer Center Support (Core) Grant P30-CA14051)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Award KL2 TR001100)en_US
dc.language.isoen_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/ncomms12685en_US
dc.rightsCreative Commons Attribution 4.0 International Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.sourceNatureen_US
dc.titleClonal dynamics following p53 loss of heterozygosity in Kras-driven cancersen_US
dc.typeArticleen_US
dc.identifier.citationMuzumdar, Mandar Deepak et al. “Clonal Dynamics Following p53 Loss of Heterozygosity in Kras-Driven Cancers.” Nature Communications 7 (2016): 12685. © 2017 Macmillan Publishers Limiteden_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorDorans, Kimberly
dc.contributor.mitauthorChung, Katherine Minjee
dc.contributor.mitauthorRobbins, Rebecca
dc.contributor.mitauthorTammela, Tuomas
dc.contributor.mitauthorGocheva, Vasilena
dc.contributor.mitauthorJacks, Tyler E.
dc.contributor.mitauthorLi, Carman Man Chung
dc.contributor.mitauthorMuzumdar, Mandar
dc.relation.journalNature Communicationsen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsMuzumdar, Mandar Deepak; Dorans, Kimberly Judith; Chung, Katherine Minjee; Robbins, Rebecca; Tammela, Tuomas; Gocheva, Vasilena; Li, Carman Man-Chung; Jacks, Tyleren_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-3675-6961
dc.identifier.orcidhttps://orcid.org/0000-0002-7799-6454
dc.identifier.orcidhttps://orcid.org/0000-0001-5785-8911
dc.identifier.orcidhttps://orcid.org/0000-0002-4450-7570
dspace.mitauthor.errortrue
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record